NASDAQ : ICUI
ICU Medical, Inc. — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 164.62 USD (Nov 2, 2026, 10:21 AM EST) · Market cap 4.12B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 4.06B |
| Enterprise Value | 5.05B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 25.01M |
| Shares Outstanding | 25.01M |
| Shares Change (YoY) | +2.28% |
| Shares Change (QoQ) | -0.55% |
| Owned by Insiders (%) | 1.77% |
| Owned by Institutions (%) | 105.53% |
| Float | 24.56M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 134.90 |
| Forward PE | 52.72 |
| PS Ratio | 1.88 |
| Forward PS | 1.82 |
| PB Ratio | 1.89 |
| P/TBV Ratio | 40.69 |
| P/FCF Ratio | 26.57 |
| P/OCF Ratio | 17.18 |
| PEG Ratio | 4.79 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 167.67 |
| EV / Sales | 2.34 |
| EV / EBITDA | 15.47 |
| EV / EBIT | 40.41 |
| EV / FCF | 33.01 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.43 |
| Quick Ratio | 1.00 |
| Debt / Equity | 0.60 |
| Debt / EBITDA | 3.76 |
| Debt / FCF | 8.42 |
| Interest Coverage | 1.52 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 1.41% |
| Return on Assets (ROA) | 1.93% |
| Return on Invested Capital (ROIC) | 3.96% |
| Return on Capital Employed (ROCE) | 3.60% |
| Weighted Average Cost of Capital (WACC) | 8.05% |
| Revenue Per Employee | $166,123 |
| Profits Per Employee | $2,315 |
| Employee Count | 13,000 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 2.18 |
Taxes
| Measure | Value |
|---|
| Income Tax | -30.96M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.87 |
| 52-Week Price Change | +35.22% |
| 50-Day Moving Average | 163.81 |
| 200-Day Moving Average | 148.63 |
| Relative Strength Index (RSI) | 48.04 |
| Average Volume (20 Days) | 219,459 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 1.71M |
| Short Previous Month | 1.52M |
| Short % of Shares Out | 6.85% |
| Short % of Float | 6.98% |
| Short Ratio (days to cover) | 6.84 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 2.16B |
| Gross Profit | 826.25M |
| Operating Income | 124.85M |
| Pretax Income | -866,000 |
| Net Income | 30.09M |
| EBITDA | 326.12M |
| EBIT | 124.85M |
| Earnings Per Share (EPS) | $1.20 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 302.64M |
| Total Debt | 1.29B |
| Net Cash | -984.52M |
| Net Cash Per Share | -$39.37 |
| Equity (Book Value) | 2.15B |
| Book Value Per Share | 86.05 |
| Working Capital | 712.54M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 236.37M |
| Capital Expenditures | -83.54M |
| Depreciation & Amortization | 201.27M |
| Net Borrowing | -111.84M |
| Free Cash Flow | 152.83M |
| FCF Per Share | $6.11 |
Margins
| Measure | Value |
|---|
| Gross Margin | 38.26% |
| Operating Margin | 5.78% |
| Pretax Margin | -0.04% |
| Profit Margin | 1.39% |
| EBITDA Margin | 15.10% |
| EBIT Margin | 5.78% |
| FCF Margin | 7.08% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.28% |
| Shareholder Yield | -2.28% |
| Earnings Yield | 0.74% |
| FCF Yield | 3.76% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $193.38 |
| Price Target Difference | 19.09% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 2.41% |
| EPS Growth Forecast (3Y) | 10.13% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Mar 18, 2002 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 2.21 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |